chromic phosphate has been researched along with phosphoric acid, trisodium salt in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boccio, JR; Caro, RA; Lanari, E; Nicolini, JO; Ughetti, R; Zubillaga, MB | 2 |
| Balon, H; Brill, DR; Dillehay, GL; Ellerbroek, NA; Gaspar, LE; Grigsby, PW; Macklis, RM; Mauch, PM; Mian, TA; Potters, L; Silberstein, EB; Williams, TR; Wong, JC | 1 |
3 other study(ies) available for chromic phosphate and phosphoric acid, trisodium salt
| Article | Year |
|---|---|
Use of colloids of chromic [32P] phosphate in treatment of solid tumors.
Topics: Adenocarcinoma; Animals; Chromium Compounds; Colloids; Female; Mammary Neoplasms, Experimental; Metabolic Clearance Rate; Phosphates; Phosphorus Radioisotopes; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1996 |
Great particles [32P]chromic phosphate for treatment of solid tumors.
Topics: Adenocarcinoma; Animals; Chromium Compounds; Feces; Female; Injections; Mammary Neoplasms, Experimental; Phosphates; Rats; Rats, Sprague-Dawley; Remission Induction; Treatment Outcome; Urine | 1996 |
Practice guideline for the performance of therapy with unsealed radiopharmaceutical sources.
Topics: Antibodies, Monoclonal; Ascites; Bone Neoplasms; Chromium Compounds; Humans; Hyperthyroidism; Iodine Radioisotopes; Lymphoma, Non-Hodgkin; Organometallic Compounds; Organophosphorus Compounds; Pain; Patient Isolation; Phosphates; Pleural Effusion, Malignant; Polycythemia Vera; Radiation Protection; Radiopharmaceuticals; Sodium Iodide; Strontium Radioisotopes; Thrombocytopenia; Thyroid Neoplasms; Yttrium Radioisotopes | 2006 |